Navigation Links
Large-scale investment catapults CAMH's mental illness and addiction research forward
Date:8/20/2008

The Centre for Addiction and Mental Health (CAMH) is proud to announce a landmark investment of $15 million by the Canada Foundation for Innovation (CFI) into research that will propel the understanding, intervention, treatment and prevention of mental illness and addiction to the next level of excellence.

This funding from the Large-Scale Institutional Endeavours component of CFI's Research Hospital Fund will allow CAMH to leverage our scientific strengths, and transform lives with a new integrated, multi-disciplinary and innovative research environment.

"This unparalleled support and endorsement is the engine that will drive real change for people impacted by mental illness and addiction," said CAMH Vice President of Research Dr. Bruce Pollock today. "The new environment that we can now build as part of our bold redevelopment will greatly increase the opportunities for researchers, clients, and partners to work together to generate timely, relevant research that can seamlessly translate into clinical practice that provides optimal care."

CFI's contribution, the largest individual grant in CAMH's history, kicks off a $38 million project that will enable CAMH to focus on transforming lives across six research themes: Schizophrenia, Mood Disorders, Addictions, Community Health & Knowledge Exchange, Neuroimaging, Pharmacogentics and Neuroscience. With the additional financial support coming from donors through the CAMH Foundation, this integrated and pioneering project will address key issues such as;

  • Optimizing treatment across mental illness and substance use disorders, including the development of individualized treatment based on molecular genetics

  • Translating discoveries into improved clinical practice, prevention and intervention strategies

  • Reaching out to underserved and understudied communities such as First Nations, remote populations, the workplace, women, the elderly, and childr
    '/>"/>

Contact: Michael Torres
michael_torres@camh.net
416-595-6015
Centre for Addiction and Mental Health
Source:Eurekalert

Page: 1 2

Related biology news :

1. Open access to large-scale drug discovery data
2. Neurotechnology Announces MegaMatcher 2.1 SDK for Development of Large-scale AFIS and Multi-biometric Face-Fingerprint Identification Systems
3. Surprising discovery from first large-scale analysis of biodiversity and biogeography of viruses
4. Are existing large-scale simulations of water dynamics wrong?
5. Texas Hospital nations first to use large-scale cocoon strategy against whooping cough
6. Microarray sequence capture speeds large-scale resequencing of targeted genomic regions
7. Europe-wide investment in lipid research will help tackle disease, says new report
8. Sanitation investment in poor countries would yield $9-to-1 benefits in productivity, health: UN
9. Using live fish, new tool a sentinel for environmental contamination
10. Experimental chemotherapy regimen shows promise in treating advanced lung cancer
11. L-1 Identity Solutions to Hold Supplemental Second Quarter 2008 Financial Results Q&A Conference Call at 2:00p.m. (ET) Today
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/8/2009)...story of diatoms -- abundant oceanic plankton that...e air each year -- needs to be rewritten, accordin...t after a sudden rise in species numbers, diatoms ...ends that coincided with severe global cooling. ,... journal Nature . , The research casts doubt on ...
(Date:1/8/2009)...come in rapid succession, the extent of damage to ...hose events, according to a new study published in...focused on tree species common to the Everglades i...growth rates and were less likely to die when subj...e versa. The findings could have significant impli...
(Date:1/8/2009)...al journal that publishes original research contri...aspects of entomology, plant pathology, virology, ...es, fungicides, herbicides and other biocides. Em...s and diseases. , Phytoparasitica also publish...s. Guest editorials written by reputable scientis...
(Date:1/7/2009)...PRNewswire/ -- WCC Smart Search & Match, the,...tch software, today,announced that Tarvinder Semb...les for the ID market. , Mr. Sembhi is a ve...t,industry. He was most recently President of 4G ...strategic product development, corporate branding ...
Breaking Biology News(10 mins):Decline of carbon-dioxide-gobbling plankton coincided with ancient global cooling 2Sequence matters in droughts and floods 2Springer expands its portfolio in plant sciences with Phytoparasitica 2ACS Systems Improving Delivery of Healthcare in Malta 17060 1ACS Systems Improving Delivery of Healthcare in Malta 17060 2ACS Systems Improving Delivery of Healthcare in Malta 17060 3Limited transparency in federal nanotech research may hamper development 4665 1Limited transparency in federal nanotech research may hamper development 4665 2Mouth Swab May One Day Diagnose Lung Cancer 17056 1Mouth Swab May One Day Diagnose Lung Cancer 17056 2Mouth Swab May One Day Diagnose Lung Cancer 17056 3APIC Statement on April 16 Congressional Hearing on Healthcare Associated Infections 3A A Preventable Epidemic 17051 1APIC Statement on April 16 Congressional Hearing on Healthcare Associated Infections 3A A Preventable Epidemic 17051 2
...ly used organic insecticide, a plucky bacterium kn...uires the assistance of other microbes to perform ... Writing in the Sept. 26 issue of the Proceedings ... of researchers from the University of Wisconsin-M... bacteria that colonize the insect gut, Bt is unab...
...t how the distance marine larvae travel varies wit...on and management of fish, shellfish and other mar...versity of North Carolina at Chapel Hill. , Most m...es, reproduces via larvae that drift far along oce...ions. The distance larvae travel before maturing, ...
...mos National Laboratory have developed a method fo...osives used in bombs. Based on knowledge of bee b...tool in the fight against the use of improvised ex... vulnerability for American military troops abroad.... , By studying bee behavior and testing and impr...
...nce that the dinosaurs and most their contemporari...r impact, according to a paleontologist who says m..., and climate changes culminated in the end of the...n fact, have been the lesser and earlier of a seri...life on Earth for more than 500,000 years, say Pri...
Other Biology News:Most widely used organic pesticide requires help to kill 2Most widely used organic pesticide requires help to kill 3Ocean temperature predicts spread of marine species 2Detecting explosives with honeybees 2Far more than a meteor killed dinos 2Far more than a meteor killed dinos 3
(Date:1/8/2009)...re-FirstCall/ -- Orexigen(R) Therapeutics, Inc.,(... four Phase 3 trials of its,lead investigational ...,(SR)/bupropion SR) met its co-primary and key sec... in body weight, improvements in markers of,cardi...ving measures. , In this trial, which inclu...
(Date:1/8/2009)...PRNewswire/ -- The Nano Science and Technology I... Conference & Expo 2009 will take place May 3-...in Houston, Texas. Now in its 12th year, the larg...ected to attract a community of more than 5,000 Na...gather to promote advanced research and best pract...
(Date:1/8/2009)...-FirstCall/ -- Allscripts announced today that,Tu...ompany, has signed a,definitive agreement to rese...Health Record (EHR) and practice management soluti...newscom.com/cgi-bin/prnh/20081013/AQM041LOGO ) ,...g forms management solutions,for the health care ...
(Date:1/8/2009)...swire-FirstCall/ -- BioCryst Pharmaceuticals, Inc....nehouse, President and Chief Executive Officer and... BioCryst, will present a corporate update at the ...hursday, January 15, 2009 at 7:30 a.m. Pacific Tim...9 in San Francisco. , , A link to a live audio ...
Breaking Biology Technology:Orexigen(R) Therapeutics Announces First of Four Phase 3 Trials of Contrave(R) Meets Co-Primary and Key Secondary Endpoints 2Orexigen(R) Therapeutics Announces First of Four Phase 3 Trials of Contrave(R) Meets Co-Primary and Key Secondary Endpoints 3Orexigen(R) Therapeutics Announces First of Four Phase 3 Trials of Contrave(R) Meets Co-Primary and Key Secondary Endpoints 4Orexigen(R) Therapeutics Announces First of Four Phase 3 Trials of Contrave(R) Meets Co-Primary and Key Secondary Endpoints 5Orexigen(R) Therapeutics Announces First of Four Phase 3 Trials of Contrave(R) Meets Co-Primary and Key Secondary Endpoints 6Orexigen(R) Therapeutics Announces First of Four Phase 3 Trials of Contrave(R) Meets Co-Primary and Key Secondary Endpoints 7NSTI Announces the 12th Annual Nanotech Conference & Expo 2009 May 3-7, at the George R. Brown Convention Center in Houston, Texas 2NSTI Announces the 12th Annual Nanotech Conference & Expo 2009 May 3-7, at the George R. Brown Convention Center in Houston, Texas 3NSTI Announces the 12th Annual Nanotech Conference & Expo 2009 May 3-7, at the George R. Brown Convention Center in Houston, Texas 4Tully-Wihr Company Selects Web-Based Allscripts Electronic Health Record for 100 Northern California Physicians 2Tully-Wihr Company Selects Web-Based Allscripts Electronic Health Record for 100 Northern California Physicians 3Tully-Wihr Company Selects Web-Based Allscripts Electronic Health Record for 100 Northern California Physicians 4Tully-Wihr Company Selects Web-Based Allscripts Electronic Health Record for 100 Northern California Physicians 5BioCryst to Present at the J.P. Morgan 27th Annual Healthcare Conference 2BioCryst to Present at the J.P. Morgan 27th Annual Healthcare Conference 3
...half dozen great products that may never see the l...idely from unique hardware devices to much-needed ...ile services and beyond. Each concept is carefully...s has been done and each product meets a real and ...eurs who designed these products are smart and det...
...ernational, Inc. announced Monday the U.S. Food a...nd strength for Hectorol (doxercalciferol) Capsule...urrently approved for the treatment of secondary h...the United States, and is now approved for the tre... (stages three and four) of chronic kidney disease...
...hnology professionals often face the challenge of ...nt solutions designed to maximize both storage and...asy-to-use solutions for their users. PKWare has a...ned for enterprise customers that seek encryption .... The company also introduced a new PKZip version ...
...ave announced they will work together to produce r...shorter charging times. , ,Sanyo will be working w...ays can recharge Nickel Metal Hydride, or NiMH, ba...trol, is a system that puts a pressure control in ...rather than allowing the charger free reign over t...
Other Biology Technology:Where have all the angels gone? 2Where have all the angels gone? 3Where have all the angels gone? 4FDA approves Bone Cares Hectorol for treatment of kidney disease 2PKWare launches new enterprise product line, adds new features to PKZip 2PKWare launches new enterprise product line, adds new features to PKZip 3
Purified Mouse anti-Hu p120 Catenin (pT916) Storage Temperature: Refrigerate(2 to 8C)
Request Info
ROCK-1 (cleaved) Monoclonal Ab 100 ug purified mouse monoclonal antibody. Clone# 12M03. Reacts with human. Tested in Western blot analysis.
Anti-Cullin-1 Host: rabbit polyclonal Species Reactivity: human, mouse Applications: IHC(P), WB, IP Storage: 4C
Biology Products: